Quince Therapeutics Price Target Announced at $70.00/Share by Rodman & Renshaw
Ratings actions from Benzinga: GMT) Quince Therapeutics Initiated at Buy by Rodman & RenshawRatings actions from Benzinga
Ratings actions from Benzinga: GMT) Quince Therapeutics Initiated at Buy by Rodman & RenshawRatings actions from Benzinga